Exposure to fungicide, tolyfluanid, disrupts energy metabolism

Mice exposed to the fungicide tolyfluanid (TF) showed metabolic changes similar to those that signify the development of the metabolic syndrome. The results, which were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

Metabolic syndrome is a cluster of conditions including increased blood pressure, level, excess body fat around the waist and abnormal . Together these conditions increase the risk of heart disease, stroke and diabetes.

Rates of occurrence of metabolic diseases such as obesity and diabetes are continuing to increase worldwide. Although poor diet and lack of physical activity are primary causes of the majority of metabolic disease, environmental factors have increasingly been implicated as important contributing causes that may increase the risks of developing metabolic diseases brought on by lifestyle.

"Recently, the attention of scientists has been attracted to endocrine-disrupting chemicals (EDCs), compounds that are suspected of promoting the development of various metabolic disorders via their capacity to impact hormonal and metabolic signaling pathways," said lead author Shane Regnier, a doctoral candidate at the University of Chicago's Committee for Molecular Metabolism & Nutrition. "Our study showed one potential EDC, an agricultural fungicide called tolylfluanid (TF), led to in including accumulation of body fat, disruption of glucose metabolism, and reduction of adipose insulin sensitivity."

Adult male mice that consumed a diet containing TF at 100 ppm for 12 weeks showed the types of changes in fasting blood glucose and adipose accumulation that may signify development of . In a separate study, mice were exposed to TF only during fetal development and as newborns. When examined at the time of weaning, the young mice displayed reduced body weight, a symptom that has been associated with an increased risk of metabolic disease later in life. These mice were followed to adulthood, and, although experiencing no further contact with TF, male mice that had been exposed only before and immediately after birth nevertheless displayed impaired glucose tolerance as adults.

The results of these two studies suggest that exposure to TF may promote the development of in humans. While TF levels have been measured in some food crops, in agricultural runoff, and in ground water, TF levels have not been measured in humans. The authors of the study suggest that the results of their two mouse experiments indicate that efforts should be made to characterize exposure of humans to TF to determine whether similar metabolic impacts are seen in humans and that continued use of TF should be carefully considered.

Although approximately 150,000 unique chemicals are registered with the European Chemicals Agency, most are tested only for acute toxicity and carcinogenic capacity. "We are only beginning to understand the role that human-made chemicals play in causing human disease," said Regnier. "The potential for chronic, low-dose exposure to impact and elicit human disease has only begun to be investigated," he added.

add to favorites email to friend print save as pdf

Related Stories

Inflammation in fat tissue helps prevent metabolic disease

Jun 18, 2014

Chronic tissue inflammation is typically associated with obesity and metabolic disease, but new research from UT Southwestern Medical Center now finds that a level of "healthy" inflammation is necessary to prevent metabolic ...

Gene behind unhealthy adipose tissue identified

May 22, 2014

Researchers at Karolinska Institutet in Sweden have for the first time identified a gene driving the development of pernicious adipose tissue in humans. The findings imply, which are published in the scientific ...

Metabolic syndrome is similar in different age groups

Feb 13, 2014

Metabolic risk factors cluster similarly in children and adults, according to a study carried out at the University of Eastern Finland. Furthermore, in adults, the clustering of these risk factors increases the risk of premature ...

Fatty liver disease prevented in mice

Jun 03, 2014

(Medical Xpress)—Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide. Blocking a path that delivers dietary ...

Recommended for you

User comments